First Time Loading...
M

MegaMD Co Ltd
KOSDAQ:133750

Watchlist Manager
MegaMD Co Ltd
KOSDAQ:133750
Watchlist
Price: 2 280 KRW -1.3% Market Closed
Updated: Apr 28, 2024

Intrinsic Value

MegaMD Co., Ltd. engages in the provision of online training and education services. [ Read More ]

The intrinsic value of one MegaMD Co Ltd stock under the Base Case scenario is 1 619.49 KRW. Compared to the current market price of 2 280 KRW, MegaMD Co Ltd is Overvalued by 29%.

Key Points:
Intrinsic Value
Base Case
1 619.49 KRW
Overvaluation 29%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation Backtest
MegaMD Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MegaMD Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
MegaMD Co Ltd

Provide an overview of the primary business activities
of MegaMD Co Ltd.

What unique competitive advantages
does MegaMD Co Ltd hold over its rivals?

What risks and challenges
does MegaMD Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for MegaMD Co Ltd.

Provide P/S
for MegaMD Co Ltd.

Provide P/E
for MegaMD Co Ltd.

Provide P/OCF
for MegaMD Co Ltd.

Provide P/FCFE
for MegaMD Co Ltd.

Provide P/B
for MegaMD Co Ltd.

Provide EV/S
for MegaMD Co Ltd.

Provide EV/GP
for MegaMD Co Ltd.

Provide EV/EBITDA
for MegaMD Co Ltd.

Provide EV/EBIT
for MegaMD Co Ltd.

Provide EV/OCF
for MegaMD Co Ltd.

Provide EV/FCFF
for MegaMD Co Ltd.

Provide EV/IC
for MegaMD Co Ltd.

Compare the intrinsic valuations
of MegaMD Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of MegaMD Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of MegaMD Co Ltd compared to its peers.

Compare the P/E ratios
of MegaMD Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing MegaMD Co Ltd with its peers.

Analyze the financial leverage
of MegaMD Co Ltd compared to its main competitors.

Show all profitability ratios
for MegaMD Co Ltd.

Provide ROE
for MegaMD Co Ltd.

Provide ROA
for MegaMD Co Ltd.

Provide ROIC
for MegaMD Co Ltd.

Provide ROCE
for MegaMD Co Ltd.

Provide Gross Margin
for MegaMD Co Ltd.

Provide Operating Margin
for MegaMD Co Ltd.

Provide Net Margin
for MegaMD Co Ltd.

Provide FCF Margin
for MegaMD Co Ltd.

Show all solvency ratios
for MegaMD Co Ltd.

Provide D/E Ratio
for MegaMD Co Ltd.

Provide D/A Ratio
for MegaMD Co Ltd.

Provide Interest Coverage Ratio
for MegaMD Co Ltd.

Provide Altman Z-Score Ratio
for MegaMD Co Ltd.

Provide Quick Ratio
for MegaMD Co Ltd.

Provide Current Ratio
for MegaMD Co Ltd.

Provide Cash Ratio
for MegaMD Co Ltd.

What is the historical Revenue growth
over the last 5 years for MegaMD Co Ltd?

What is the historical Net Income growth
over the last 5 years for MegaMD Co Ltd?

What is the current Free Cash Flow
of MegaMD Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for MegaMD Co Ltd.

Financials

Balance Sheet Decomposition
MegaMD Co Ltd

Current Assets 49B
Cash & Short-Term Investments 41.7B
Receivables 2.4B
Other Current Assets 4.9B
Non-Current Assets 35.7B
Long-Term Investments 15.8B
PP&E 9.1B
Intangibles 4.5B
Other Non-Current Assets 6.4B
Current Liabilities 18.5B
Accounts Payable 2.4B
Accrued Liabilities 1B
Other Current Liabilities 15.1B
Non-Current Liabilities 3.9B
Long-Term Debt 2.2B
Other Non-Current Liabilities 1.7B
Efficiency

Earnings Waterfall
MegaMD Co Ltd

Revenue
36B KRW
Cost of Revenue
-16B KRW
Gross Profit
20B KRW
Operating Expenses
-24B KRW
Operating Income
-3.9B KRW
Other Expenses
741.9m KRW
Net Income
-3.2B KRW

Free Cash Flow Analysis
MegaMD Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

MegaMD Co Ltd's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

36/100
Profitability
Score

MegaMD Co Ltd's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

MegaMD Co Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
60/100
Solvency
Score

MegaMD Co Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
MegaMD Co Ltd

There are no price targets for MegaMD Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
MegaMD Co Ltd

1M 1M
-15%
6M 6M
+2%
1Y 1Y
-12%
3Y 3Y
-59%
5Y 5Y
+6%
10Y 10Y
-27%
Annual Price Range
2 280
52w Low
1 910
52w High
3 325
Price Metrics
Average Annual Return 9.64%
Standard Deviation of Annual Returns 33.26%
Max Drawdown -71%
Shares Statistics
Market Capitalization 50.3B KRW
Shares Outstanding 22 074 985
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

MegaMD Co Ltd

Country

Korea

Industry

Diversified Consumer Services

Market Cap

50.3B KRW

Dividend Yield

0%

Description

MegaMD Co., Ltd. engages in the provision of online training and education services. The company is headquartered in Seoul, Seoul. The company went IPO on 2015-12-18. The firm offers a range of educational programs, services and products including test preparation courses for medical education eligibility tests (MEETs), test preparation courses for dental education eligibility tests (DEETs), test preparation courses for pharmacy education eligibility tests (PEETs), test preparation courses for legal education eligibility tests (LEETs) and online education. The firm also wholesales teaching materials about above courses.

Contact

SEOUL
Seoul
4F, Younglim Bldg., 81, Banpo-daero, Seocho-gu
+82269183505
http://www.megamd.co.kr

IPO

2015-12-18

Employees

-

Officers

Senior Managing Director
Mr. Suk-Cheol Kim

See Also

Discover More
What is the Intrinsic Value of one MegaMD Co Ltd stock?

The intrinsic value of one MegaMD Co Ltd stock under the Base Case scenario is 1 619.49 KRW.

Is MegaMD Co Ltd stock undervalued or overvalued?

Compared to the current market price of 2 280 KRW, MegaMD Co Ltd is Overvalued by 29%.